Andexanet-Alfa-Associated Heparin Resistance in the Context of Hemorrhagic Stroke

被引：0
|
作者：
Michael Müther
Wolfram Schwindt
Rolf Michael Mesters
Jens Minnerup
Paul Stracke
Markus Holling
Heinz Wiendl
Walter Stummer
机构：
[1] University Hospital Münster,Department of Neurosurgery
[2] University Hospital Münster,Section of Interventional Neuroradiology, Department of Radiology
[3] University Hospital Münster,Department of Medicine A
[4] University Hospital Münster,Hematology, Oncology, Hemostaseology, and Pneumology
来源：
Neurocritical Care | 2022年 / 37卷
关键词：
Hemorrhagic stroke; Anticoagulants; Heparin; PRT064445; Factor Xa inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：372 / 376
页数：4
相关论文
共 50 条
  • [21] Andexanet Alfa Use in Cardiac Surgical Patients: A Xa Inhibitor and Heparin Reversal Agent
    Levy, Jerrold H.
    Connors, Jean M.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2021, 35 (01) : 265 - 266
  • [22] Andexanet-alfa/heparinHeparin resistance and lack of efficacy: case report
    Reactions Weekly, 2023, 1966 (1) : 35 - 35
  • [23] Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation
    Carpenter, Elise
    Singh, Divita
    Dietrich, Eric
    Gums, John
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2019, 10
  • [24] Reversal of Heparin-Induced Anticoagulation By Andexanet Alfa, a Universal Antidote for Factor Xa Inhibitors
    Lu, Genmin
    Lin, Joyce
    Curnutte, John T.
    Conley, Pamela B.
    BLOOD, 2015, 126 (23)
  • [25] Andexanet Alfa for the Management of Acute Major Bleeding Associated with FXa Inhibitors
    Connolly, Stuart J.
    Milling, Truman J.
    Eikelboom, John W.
    Gibson, C. Michael
    Curnutte, John T.
    Gold, Alex
    Lu, Genmin
    Conley, Pamela B.
    Verhamme, Peter
    Schmidt, Jeannot
    Middeldorp, Saskia
    Cohen, Alexander T.
    Beyer-Westendorf, Jan
    Albaladejo, Pierre
    Lopez-Sendon, Jose
    Goodman, Shelly
    Leeds, Janet M.
    Siegal, Deborah M.
    Zotova, Elena
    Nakamya, Juliet
    Lim, W. Ting
    Crowther, Mark
    NEUROLOGY, 2017, 88
  • [26] Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
    Connolly, Stuart J.
    Milling, Truman J., Jr.
    Eikelboom, John W.
    Gibson, C. Michael
    Curnutte, John T.
    Gold, Alex
    Bronson, Michele D.
    Lu, Genmin
    Conley, Pamela B.
    Verhamme, Peter
    Schmidt, Jeannot
    Middeldorp, Saskia
    Cohen, Alexander T.
    Beyer-Westendorf, Jan
    Albaladejo, Pierre
    Lopez-Sendon, Jose
    Goodman, Shelly
    Leeds, Janet
    Wiens, Brian L.
    Siegal, Deborah M.
    Zotova, Elena
    Meeks, Brandi
    Nakamya, Juliet
    Lim, W. Ting
    Crowther, Mark
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (12): : 1131 - 1141
  • [27] Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
    Siddiqui, Fakiha
    Tafur, Alfonso
    Bontekoe, Emily
    Iqbal, Omer
    Jeske, Walter
    Mehrotra, Siddharth
    Hoppensteadt, Debra
    Ramacciotti, Eduardo
    Fareed, Jawed
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2020, 26
  • [28] Andexanet Alfa for Edoxaban Reversal and Associated Thromboelastography Changes in Surgical Pulmonary Embolectomy
    Fukuda, Yu
    Yoshinaga, Koichi
    Kondo, Shin
    Iizuka, Yusuke
    Sanui, Masamitsu
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [29] Comment on: Andexanet alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
    Lier, H.
    Grottke, O.
    ANAESTHESIST, 2016, 65 (12): : 940 - 941
  • [30] Effects of Andexanet Alfa on Thrombin Generation in Bleeding Associated with Factor Xa Inhibitors
    Coppens, Michiel
    Xu, Lizhen
    Bavalia, Roisin
    Middeldorp, Saskia
    Verhamme, Peter
    Eikelboom, John W.
    Crowther, Mark
    Lu, Genmin
    Yue, Patrick
    Conley, Pamela B.
    Connolly, Stuart J.
    BLOOD, 2019, 134
12345